SARAH DORF: Open Payments
NPI 1730518820 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,517 in 90 payments from 19 companies in 2025. Trend: 2023 $1,990 · 2024 $2,032 · 2025 $1,517
Food & beverage: $1,517
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $339 |
| Novo Nordisk Inc | 13 | $213 |
| Axsome Therapeutics, Inc. | 7 | $164 |
| PFIZER INC. | 11 | $143 |
| Amgen Inc. | 9 | $140 |
| Phathom Pharmaceuticals, Inc. | 6 | $89 |
| Vanda Pharmaceuticals Inc. | 3 | $64 |
| Lilly USA, LLC | 3 | $61 |
| Exact Sciences Corporation | 3 | $51 |
| Astellas Pharma US Inc | 3 | $48 |
Products named: UBRELVY, Auvelity, Wegovy, VOQUEZNA, VRAYLAR, EVENITY, NURTEC ODT, OTEZLA.
Industry payments across KY — which companies pay providers there.
